Staining of these samples using a validated antibody for GPD1 revealed reduced GPD1 expression in tumor tissue compared to normal tissue, and GPD1 expression gradually decreased with bladder cancer progression (Fig. 1F, G). The gene discussed is GPD1; the disease is urinary bladder carcinoma.